|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-01 pm EDT
|
5-day change | 1st Jan Change | ||
| 1.826 SEK | 0.00% |
|
-0.11% | -7.31% |
| Sep. 03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| Sep. 03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
| Market Cap | 272M 27.02M 24M 22.45M 20.45M 38.51M 2.6B 39.04M 105M 1.33B 101M 99.26M 4.26B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 272M 27.02M 24M 22.45M 20.45M 38.51M 2.6B 39.04M 105M 1.33B 101M 99.26M 4.26B | EV / Sales 2026 * |
2.68x | EV / Sales 2027 * | 1.9x |
| Free-Float |
83.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IRLAB A | Delayed | |
Deutsche Boerse AG
| 6IRA | Delayed |
| 1 week | -0.11% | ||
| 1 month | +3.51% | ||
| 3 months | +47.02% | ||
| 6 months | +27.51% | ||
| Current year | -7.31% |
| 1 week | 1.77 |  | 1.96 |
| 1 month | 1.6 | | 1.96 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 2.98 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 51.5 |
| 10 years | 1.17 | | 110 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2024-07-31 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 2012-12-31 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 2015-12-31 |
| Chairman | 73 | 2020-05-06 | |
Veronica Wallin
BRD | Director/Board Member | 40 | 2022-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/1/26 | Buy | Chairman | 31,000 | 38.8588% | ||
| 7/1/26 | Buy | Chief Technology Officer | 4,016,742 | - | ||
| 7/1/26 | Buy | Chief Executive Officer | 183,858 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.11% | -37.25% | -75.26% | 27.2M | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,031B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 638B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 462B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 359B | |
| -0.03% | -3.96% | +23.63% | +39.35% | 335B | |
| -1.58% | -0.76% | +13.50% | +25.77% | 273B | |
| -2.02% | -2.97% | -3.25% | +8.38% | 253B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 228B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 185B | |
| Average | -1.26% | -1.23% | +21.00% | +44.08% | 376.39B | |
| Weighted average by Cap. | -1.25% | -1.89% | +30.52% | +69.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 101M 10.07M 8.95M 8.37M 7.62M 14.35M 970M 14.55M 39.18M 494M 37.81M 36.99M 1.59B | 143M 14.25M 12.66M 11.84M 10.79M 20.31M 1.37B 20.59M 55.43M 699M 53.5M 52.34M 2.24B |
| Net income | -36.1M -3.59M -3.19M -2.98M -2.72M -5.12M -346M -5.19M -13.97M -176M -13.49M -13.2M -566M | 34.6M 3.44M 3.06M 2.86M 2.61M 4.91M 332M 4.97M 13.39M 169M 12.93M 12.65M 542M |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
Nov. 10
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | SEK 1.826 | 0.00% | 1,010,590 |
| 26-09-30 | SEK 1.826 | -0.76% | 662,220 |
| 26-09-29 | SEK 1.840 | -2.44% | 1,167,762 |
| 26-09-28 | SEK 1.886 | -0.74% | 587,436 |
| 26-09-25 | SEK 1.900 | +3.94% | 919,895 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
Select your edition
All financial news and data tailored to specific country editions
